Wee1 inhibitor MK1775 sensitizes KRAS mutated NSCLC cells to sorafenib.
about
Wee1 inhibitor MK1775 sensitizes KRAS mutated NSCLC cells to sorafenib.
description
2018 nî lūn-bûn
@nan
2018年の論文
@ja
2018年学术文章
@wuu
2018年学术文章
@zh
2018年学术文章
@zh-cn
2018年学术文章
@zh-hans
2018年学术文章
@zh-my
2018年学术文章
@zh-sg
2018年學術文章
@yue
2018年學術文章
@zh-hant
name
Wee1 inhibitor MK1775 sensitizes KRAS mutated NSCLC cells to sorafenib.
@en
Wee1 inhibitor MK1775 sensitizes KRAS mutated NSCLC cells to sorafenib.
@nl
type
label
Wee1 inhibitor MK1775 sensitizes KRAS mutated NSCLC cells to sorafenib.
@en
Wee1 inhibitor MK1775 sensitizes KRAS mutated NSCLC cells to sorafenib.
@nl
prefLabel
Wee1 inhibitor MK1775 sensitizes KRAS mutated NSCLC cells to sorafenib.
@en
Wee1 inhibitor MK1775 sensitizes KRAS mutated NSCLC cells to sorafenib.
@nl
P2093
P2860
P50
P1433
P1476
Wee1 inhibitor MK1775 sensitizes KRAS mutated NSCLC cells to sorafenib
@en
P2093
Alice Iezzi
Marina C Garassino
Michele Tomanelli
Rossana Valerio
P2860
P2888
P356
10.1038/S41598-017-18900-Y
P407
P577
2018-01-17T00:00:00Z